Skip to main content

Table 4 Multivariate Cox regression analysis of overall survival in patients treated with anti-inflammatory drugs

From: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia

 

Multivariate analysis

HR (95% CI)

P value

Age (year)

1.04 (1.01–1.08)

0.022

Male

2.13 (0.94–4.79)

0.068

FVC % predicted (%)

0.95 (0.93–0.98)

< 0.001

BAL lymphocytosis

0.31 (0.13–0.75)

0.009

Anti-fibrotic drugs

1.94 (0.90–4.19)

0.090

  1. BAL bronchoalveolar lavage, CI confidence interval, FVC forced vital capacity, HR hazard ratio